Corvus Pharmaceuticals (CRVS) Operating Income Growth (1y) (2016 - 2026)
Corvus Pharmaceuticals (CRVS) Operating Income Growth (1y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn | 1,386.07% |
| 10 | Corvus Pharmaceuticals | 1.19 Bn | 957.54 Mn | - | -49.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -49.94% |
| Sep 30, 2025 | -45.72% |
| Jun 30, 2025 | -72.87% |
| Mar 31, 2025 | -58.68% |
| Sep 30, 2024 | -30.49% |
| Jun 30, 2024 | -5.57% |
| Mar 31, 2024 | 4.88% |
| Dec 31, 2023 | 0.26% |
| Sep 30, 2023 | 55.42% |
| Jun 30, 2023 | 19.83% |
| Mar 31, 2023 | 11.32% |
| Dec 31, 2022 | 16.80% |
| Sep 30, 2022 | -37.87% |
| Jun 30, 2022 | 37.88% |
| Mar 31, 2022 | 35.44% |
| Dec 31, 2021 | 31.07% |
| Sep 30, 2021 | 8.11% |
| Jun 30, 2021 | -4.86% |
| Mar 31, 2021 | 13.46% |
| Dec 31, 2020 | 13.65% |